Amphetamine-based stimulants are the most potent ADHD medications on a milligram-for-milligram basis, roughly twice as strong as methylphenidate. In clinical dose conversion, 1 mg of amphetamine produces the same effect as 2 mg of methylphenidate. But potency and real-world effectiveness aren’t the same thing, and understanding the difference matters when you’re evaluating your treatment options.
What “Strongest” Actually Means
When people search for the strongest ADHD stimulant, they usually mean one of three things: which drug controls symptoms best, which one is most potent per milligram, or which formulation lasts the longest. These are separate questions with different answers.
Potency refers to how much of a drug you need to achieve a given effect. Amphetamine compounds (the active ingredient in Adderall, Vyvanse, and Dexedrine) are about twice as potent as methylphenidate compounds (the active ingredient in Ritalin, Concerta, and Focalin). That’s why Adderall’s typical doses top out around 40 mg per day while Concerta goes up to 72 mg. Both reach a similar level of symptom control at their optimal doses.
Efficacy, on the other hand, is how well a drug actually reduces ADHD symptoms at its best dose. Meta-analyses of stimulant trials in children and adolescents show that both amphetamine-based and methylphenidate-based medications produce large, clinically meaningful improvements, with effect sizes around 0.95 to 0.99 for long-acting and immediate-release formulations respectively. Statistically, the two classes do not differ in overall efficacy. So while amphetamines are more potent per milligram, they aren’t more effective when properly dosed.
Amphetamine vs. Methylphenidate Potency
The standard clinical conversion is straightforward: 1 mg of any amphetamine salt equals roughly 2 mg of methylphenidate. This holds across formulations. Dextroamphetamine (Dexedrine), mixed amphetamine salts (Adderall), and lisdexamfetamine (Vyvanse) all follow this ratio once the active drug reaches your brain. Dextroamphetamine is slightly more potent than mixed amphetamine salts because it contains only the more active molecular form, but the practical difference is small.
On the methylphenidate side, a refined version called dexmethylphenidate (Focalin) strips out the less active half of the molecule. That makes it effective at half the dose of standard methylphenidate. So 5 mg of Focalin does the same work as 10 mg of Ritalin, which does the same work as 5 mg of Adderall. All roads lead to a similar therapeutic effect.
Longest-Lasting Formulations
If “strongest” means the most sustained coverage throughout the day, the answer is Mydayis. This extended-release amphetamine capsule uses three types of drug-releasing beads (one intermediate, two delayed) to maintain therapeutic levels for up to 16 hours. For comparison, Adderall XR lasts about 10 hours, Vyvanse covers roughly 12 to 14 hours, and Concerta provides about 10 to 12 hours.
Longer duration doesn’t mean higher peak intensity. Mydayis spreads its effect over a longer window, reaching peak blood levels around 8 hours after you take it. It was designed for adolescents and adults who need coverage from morning through evening without a second dose. Whether that extended timeline is better for you depends entirely on your schedule and when your symptoms are most disruptive.
Why Optimal Dose Varies So Much
The most important thing about ADHD stimulant strength is that the “strongest” medication is whichever one works best in your specific body, and there’s no way to predict that without trying it. Research on the dopamine transporter gene (DAT1) illustrates this clearly. People who carry two copies of the less common 9-repeat version of this gene tend to respond differently to stimulants than those with more common variants. Some studies found they needed higher doses to see improvement; others found they had a more robust response at higher doses. The picture is complicated and still being refined, but the takeaway is consistent: genetics create real, measurable differences in how people respond to the same drug at the same dose.
Baseline symptom severity also plays a role. Clinical data show that how severe your ADHD is before treatment is the most significant predictor of what dose you’ll ultimately need. Two people of the same weight and age can require very different amounts of the same medication.
This is why dose titration, starting low and increasing gradually, is standard practice. The goal isn’t to reach the maximum dose. It’s to find the lowest dose that adequately controls your symptoms without intolerable side effects. That sweet spot is your optimal dose, and it has nothing to do with what works for someone else.
Higher Doses and Side Effects
More potent or higher doses do come with trade-offs. In studies of extended-release methylphenidate, 76% of patients experienced at least one adverse event at 108 mg per day compared to 54% at 36 mg per day. The most common side effects of high-dose stimulants mirror what you’d expect at any dose, just more pronounced: decreased appetite (reported in over 60% of patients on lisdexamfetamine), trouble sleeping (around 29%), irritability (26%), and weight loss (21%).
Cardiovascular concerns are often raised with higher stimulant doses, but the data is more nuanced than you might expect. One large study of children found that heart-related parameters like certain electrical intervals on an EKG were not associated with methylphenidate dose or how long kids had been taking it. A nationwide study actually found an inverse relationship, with cardiovascular events more common among children prescribed the lowest doses. This likely reflects the fact that kids who tolerate higher doses tend to be healthier overall, not that higher doses are protective.
Stimulants vs. Nonstimulants
For context, all stimulants are substantially stronger than nonstimulant ADHD medications. Meta-analyses show nonstimulants produce an effect size of about 0.57, compared to roughly 0.95 to 0.99 for stimulants. That’s a meaningful gap. Nonstimulants like atomoxetine, guanfacine, and clonidine have their place, particularly for people who can’t tolerate stimulants or have co-occurring conditions. But in terms of raw symptom reduction, stimulants as a class are clearly more effective.
Among nonstimulants, atomoxetine has an interesting wrinkle related to individual variation. It’s broken down primarily by the CYP2D6 liver enzyme, and genetic differences in that enzyme create up to a 30-fold difference in drug exposure between the fastest and slowest metabolizers. People who metabolize it slowly experience much stronger effects at the same dose, which is why genetic testing can be particularly useful for this medication.
Choosing Based on Fit, Not Potency
The practical answer to “what’s the strongest ADHD stimulant” is that amphetamines are more potent per milligram, Mydayis lasts the longest, and both major stimulant classes are equally effective when dosed properly. But none of that tells you which medication will work best for you. Roughly 70% of people respond well to the first stimulant they try, and about 90% respond to at least one of the two classes. If methylphenidate doesn’t work, switching to an amphetamine (or vice versa) often does.
What matters more than milligram potency is finding the right drug class for your biology, the right formulation for your daily schedule, and the right dose for your symptom severity. A perfectly matched moderate dose of methylphenidate will control your symptoms better than a poorly tolerated high dose of amphetamine every time.